Tag Archives: PAX6

£200,000 aniridia drug research, based and funded in the UK underway

Research into the growth of eyes with aniridia has begun, funded by Aniridia Network and two families in the UK. In 2018, for the first time, Aniridia Network excitedly partnered with Fight for Sight to offer a £15,000 grant for … Continue reading

Rate this:

Posted in ANUK news, Medical staff talking, Research | Tagged , , , , , , , , | Leave a comment

PAX6 and the Cornea: An Eye to the Future

One of the speakers at this year’s conference was Thanos Papadimitropoulos from University of Liverpool. He told us about his team’s research, funded by Fight for Sight, into a potential new therapy that may one day be able to slow down or … Continue reading

Rate this:

Posted in Research | Tagged , , , | Leave a comment

Cure for aniridia under spotlight

A new study has suggested potential eyedrop therapy for aniridia. Is the hype justified and what are the details? Aniridia is a genetic abnormality caused by mutations in the so-called ‘Master Regulator’ gene for eye development, PAX6.  Because PAX6 is … Continue reading

Rate this:

Posted in Medical staff talking, Research | Tagged , , , | 8 Comments

Run-on mutation in the PAX6 gene and chorioretinal degeneration in autosomal dominant aniridia

Purpose: To identify the causative paired box 6 (PAX6) mutation in a family with autosomal dominant aniridia. Methods: A family with autosomal dominant aniridia with three affected individuals in two generations was investigated for the causative PAX6 mutation by single strand conformation polymorphism (SSCP) … Continue reading

Rate this:

Posted in Research | Tagged | Leave a comment